SAB Biotherapeutics, Inc. - Common Stock
SAB Biotherapeutics, Inc. - Common Stock
Aktie · US78397T2024 · SABS (XNAS)
Übersicht Finanzkennzahlen
1,87 USD
0,54 % 0,01 USD
NASDAQ (XNAS) · Aktuelle Kurse und Charts bei MoneyPeak
10.06.2025 19:59

Aktuelle Kurse von SAB Biotherapeutics, Inc. - Common Stock

BörseTickerWährungLetzter UmsatzKursTagesveränderung
XNAS: NASDAQ
NASDAQ
SABS
USD
10.06.2025 19:59
1,87 USD
1,86 USD
+0,54 %

Performance

Heute Woche Monat 3 Monate 6 Monate 1 Jahr 5 Jahre
0,00 % 0,13 % 9,36 % 19,87 % -56,00 % -43,67 % -98,16 %

Firmenprofil zu SAB Biotherapeutics, Inc. - Common Stock Aktie

SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies based on human antibodies. It has applied advanced genetic engineering and antibody science to develop transchromosomic bovine herds that produce fully human antibodies targeted at specific diseases, including infectious diseases comprising COVID-19 and influenza, immune and autoimmune disorders, such as type 1 diabetes, organ transplantation, and cancer. The company uses its DiversitAb immunotherapy platform to produce fully-human polyclonal antibodies without the need for human donors. Its lead product candidates include SAB-185, a fully-human polyclonal antibody therapeutic candidate that is in Phase III clinical trial for the treatment of COVID-19; and SAB-176, a fully-human polyclonal antibody therapeutic candidate that is in development to treat or prevent severe influenza. The company's pre-clinical product candidates in development for autoimmune diseases include SAB-142 for type 1 diabetes and organ transplant induction/rejection. The company was founded in 2014 and is based in Sioux Falls, South Dakota.

Unternehmensdaten

Name SAB Biotherapeutics, Inc. - Common Stock
Firma SAB Biotherapeutics, Inc.
Symbol SABS
Website https://www.sabbiotherapeutics.com
Heimatbörse XNAS NASDAQ
ISIN US78397T2024
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Mr. Samuel J. Reich
Marktkapitalisierung 13 Mio
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,1 T
Adresse 2100 East 54th Street North, 57104 Sioux Falls
IPO Datum 2021-02-09

Kennungs-Wechsel

Datum Von Zu
25.10.2021 BCYP SABS

Ticker Symbole

Name Symbol
NASDAQ SABS

Weitere Aktien

Investoren die SAB Biotherapeutics, Inc. - Common Stock die halten, haben auch folgende Aktien im Depot:
ABBVIE 25/35
ABBVIE 25/35 Anleihe
LOWE'S CO 12/42
LOWE'S CO 12/42 Anleihe
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025